Drug Shortage Report for DIGIFAB

Last updated on 2018-05-05 History
Report ID 46307
Drug Identification Number 02361043
Brand name DIGIFAB
Common or Proper name Digoxin Immune Fab (Ovine)
Company Name BTG INTERNATIONAL INC
Market Status MARKETED
Active Ingredient(s) DIGOXIN IMMUNE FAB
Strength(s) 40MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size One vial
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-13
Estimated end date
Actual end date 2018-05-04
Shortage status Resolved
Updated date 2018-05-05
Company comments Stock released for distribution 04-May-18
Health Canada comments
Tier 3 Status No
Contact Address 300 FOUR FALLS CORPORATE CENTER, 300 CONSHOHOCKEN STATE ROAD
WEST CONSHOHOCKEN, PENNSYLVANIA
UNITED STATES 19428
Company contact information samuel.jenkinson@btgsp.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2018-05-05 English Compare
v12 2018-05-04 French Compare
v11 2018-05-04 English Compare
v10 2018-05-04 French Compare
v9 2018-05-04 English Compare
v8 2018-04-19 French Compare
v7 2018-04-19 English Compare
v6 2018-04-19 French Compare
v5 2018-04-19 English Compare
v4 2018-04-19 English Compare
v3 2018-04-19 English Compare
v2 2018-04-19 English Compare
v1 2018-04-19 English Compare

Showing 1 to 13 of 13